Piper Sandler analyst Jason Bednar maintained a Buy rating on Alpha Tau Medical Ltd (DRTS – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at $2. ...

JERUSALEM, March 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha ...

- Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and ...

- Interim results from three trials exploring the use of Alpha DaRT ® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive ...

JERUSALEM, March 12, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ®, ...

TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Alibaba Group Holding Limited, through its subsidiaries, provides technology infrastructure and marketing reach to help merchants, brands, retailers, and other businesses to engage with their ...

Representatives from Crest Architects will respond to you via e-mail. By sending this message you agree to the T&C.

Crest Ventures Ltd. key Products/Revenue Segments include Interest, Income From Real Estate Development, Income From Sale Of Share & Securities, Sale of services, Licence Fees and Dividend for the ...

After hours: March 14 at 7:58:13 PM EDT ...